Litigation Details for Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc. (D. Del. 2021)

Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc. (D. Del. 2021)

Docket		Date Filed	2021-07-01
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Jennifer L. Hall
Jury Demand	None	Referred To
Patents	8,324,225; 8,415,355; 8,685,980; 8,962,630; 9,416,136
Link to Docket	External link to docket

Details for Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc. (D. Del. 2021)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-07-01	1	Complaint	expiration of U.S. Patent Nos. 8,324,225 (“the ’225 patent”), 8,415,355 (“the ’355 patent”), 8,685,980 (“…’225 patent, the ’355 patent, the ’980 patent, the ’630 patent, the ’732 patent, the ’136 patent, the…’225 patent, the ’355 patent, the ’980 patent, the ’630 patent, the ’732 patent, the ’136 patent, the…of the ’225 patent, the ’355 patent, the ’980 patent, the ’630 patent, and the ’136 patent, an act of …of the ’225 patent, the ’355 patent, the ’980 patent, the ’630 patent, and the ’136 patent. 12	External link to document
2021-07-01	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,324,225 ; 8,415,355 ; 8,685,980… 1 July 2021 1:21-cv-00981 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document